Cleared Traditional

K925848 - IMMULITE FERRITIN

K925848 is the FDA 510(k) clearance for IMMULITE FERRITIN by Diagnostic Products Corp.. It is a Class 2 Immunology device (product code JMG) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K925848 · Diagnostic Products Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1993
Decision
56d
Days
Class 2
Risk

K925848 is an FDA 510(k) clearance for the IMMULITE FERRITIN. Classified as Radioimmunoassay (two-site Solid Phase), Ferritin (product code JMG), Class II - Special Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on January 13, 1993 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5340 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Products Corp. devices

Submission Details

510(k) Number K925848 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 1992
Decision Date January 13, 1993
Days to Decision 56 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 104d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JMG Radioimmunoassay (two-site Solid Phase), Ferritin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - JMG Radioimmunoassay (two-site Solid Phase), Ferritin

All 15
Devices cleared under the same product code (JMG) and FDA review panel - the closest regulatory comparables to K925848.
FERRITIN ON THE ACCESS IMMUNOASSAY SYSTEMS, MODEL 33020
K052082 · Beckman Coulter, Inc. · Aug 2005
TINA-QUANT FERRITIN ASSAY
K964282 · Boehringer Mannheim Corp. · Jul 1997
ELECSYS FERRITIN
K971833 · Boehringer Mannheim Corp. · Jun 1997
ACCESS FERRITIN ASSAY
K926221 · Bio-Rad Laboratories, Inc. · Jan 1993
COBAS CORE FERRITIN EIA
K920829 · Roche Diagnostic Systems, Inc. · Jun 1992
CEDIA FERRITIN ASSAY
K920318 · Microgenics Corp. · Jun 1992